Pick's disease dementia
Since Pick first reported this disease in 1892, it is called Pick’s disease. The pathological changes are mainly atrophy of the cerebral cortex, or localized changes in the frontal lobe and temporal lobe, and can also be subcortical dementia. The main manifestation of this disease is progressive intellectual disability, which is a chronic course. Its pathological changes are lobar atrophy mainly in the frontal and temporal lobes. However, the neurofibrillary tangles and senile plaques in the brain do not exceed the normal aging level.
-
Site of disease:
Brain -
Infectious :
Not contagious -
Frequent population:
Elderly population -
Related symptoms:
Irritability violent impulsive behavior inattention cognitive dysfunction motor aphasia
Related Drugs
Piracetam Capsules
Indication: Brain function improving medicine, promoting thinking and memory. It has the functions of resisting cerebral cortex hypoxia, activating brain cells, promoting phosphorus absorption and brain protein synthesis. It accelerates the speed of information transmission between the cerebral hemispheres through the callus. It can be used for concussion, brain trauma, cerebral arteriosclerosis, sequelae of cerebral vascular sclerosis, and can also be used for mental decline in the elderly and intellectual decline in children.
Manufacturer:
Jiangxi Huiren Pharmaceutical Co., Ltd.
Aniracetam Capsules
Indication: 1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in the middle-aged and elderly.
Manufacturer:
Wuxi Cathy Pharmaceuticals Ltd.
Galantamine Hydrobromide Tablets
Indication: This product is suitable for benign memory disorders, improving patients' ability of directed memory, associative learning, image recall, meaningless pattern recognition and portrait recall, etc. It also has an improving effect on memory disorders caused by dementia patients and organic brain lesions.
Compound brain protein hydrolysate tablets
Indication: It is used to improve the symptoms of craniocerebral trauma, cerebrovascular disease sequelae accompanied by memory loss and attention disorder. It has an auxiliary improvement effect on brain dysfunction, and is also used for patients with protein deficiency, neurasthenia and general protein digestion and absorption disorders.
Manufacturer:
Changchun Norman Bethune Pharmaceutical Co., Ltd.
Ergotamine mesylate sustained-release capsules
Indication: Cerebral arteriosclerosis, sequelae of concussion, sequelae of stroke and senile dementia, etc.